Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

LONDON (Reuters) – Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *